Clear, data-based financial assumptions are essential to driving a successful deal process. In a previous post, The Value of a Commercial Assessment in Supporting a Transaction, I discussed the main ways that a well-done commercial assessment can optimize both the...
With the new school year just around the corner here in Boston (and already underway in other parts of the country), transactions involving academic and research institutions are on our minds. Specifically, while research doesn’t stop during the summer vacation, as...
Once the strategic analysis is complete, the target identified and the exclusivity period is in effect, things start to get interesting in a buy-side transaction. The due diligence process provides the acquirer the opportunity to further assess strategic fit,...
Buying development or commercial stage assets is a strategy with the potential to create multiple sources of value for many small to mid-sized companies. Closing a deal on the buy side can create potential short and/or long term revenue growth, create catalysts to...
In the Life Sciences universe, most people think of biopharma and medical devices as two separate businesses — never shall the two paths cross. However, there are many overlaps and best practices that can be applied to both sectors. It is widely accepted that...
While life sciences companies are, first and foremost, scientific organizations working to advance human healthcare, they are also businesses. And, all businesses, I would argue, have to participate in the sales process on many levels. At Locust Walk, we are immersed...
